Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein

Rouslan Kotchetkov; David Susman; Divaya Bhutani; Kaspar Broch; Angela Dispenzieri; Francis K. Buadi

doi:10.1002/ijc.33571

Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein

Rouslan Kotchetkov, David Susman, Divaya Bhutani, Kaspar Broch, Angela Dispenzieri, Francis K. Buadi

Hematology

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	743-744
Number of pages	2
Journal	International Journal of Cancer
Volume	149
Issue number	3
DOIs	https://doi.org/10.1002/ijc.33571
State	Published - Aug 1 2021

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1002/ijc.33571

Cite this

@article{5fa89b372bb04c0b8825ce96da4c595a,

title = "Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein",

author = "Rouslan Kotchetkov and David Susman and Divaya Bhutani and Kaspar Broch and Angela Dispenzieri and Buadi, {Francis K.}",

year = "2021",

month = aug,

day = "1",

doi = "10.1002/ijc.33571",

language = "English (US)",

volume = "149",

pages = "743--744",

journal = "International Journal of Cancer",

issn = "0020-7136",

publisher = "Wiley-Liss Inc.",

number = "3",

}

TY - JOUR

T1 - Reply to

T2 - Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein

AU - Kotchetkov, Rouslan

AU - Susman, David

AU - Bhutani, Divaya

AU - Broch, Kaspar

AU - Dispenzieri, Angela

AU - Buadi, Francis K.

PY - 2021/8/1

Y1 - 2021/8/1

UR - http://www.scopus.com/inward/record.url?scp=85102929836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85102929836&partnerID=8YFLogxK

U2 - 10.1002/ijc.33571

DO - 10.1002/ijc.33571

M3 - Letter

C2 - 33742687

AN - SCOPUS:85102929836

SN - 0020-7136

VL - 149

SP - 743

EP - 744

JO - International Journal of Cancer

JF - International Journal of Cancer

IS - 3

ER -

Reply to: Comments on: Chemotherapy-based approach is the preferred treatment for sporadic late-onset nemaline myopathy with a monoclonal protein

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this